Daniel Recinella

Mr. Recinella has over 35 years of experience in medical devices and has taken numerous products from feasibility to commercialization.  His experience covers a wide array of devices ranging from Class I to Class III and has included the development of implants, combination products, hardware and consumables.  Most of his career has been spent in engineering (R&D and Operations) and project management, but he also has experience in product management, regulatory and clinical.

Dan started his career at Sarns (a division of 3M) where he was part of the team developing one of the first LVAD’s as well as consumables for open heart surgery procedures.  From there he moved on to Mansfield Scientific, followed by AngioDynamics where he last served as interim Chief Technology Officer before leaving in 2012.

Dan was at Veniti where he served as one of the executive level managers and led R&D, Operations, Clinical and Regulatory. He left Veniti after the company was successfully acquired by Boston Scientific in 2018.  More recently, Dan served as the EVP of Device Development for ImmunSYS, Inc, a start-up company focusing on immunotherapy treatment for adenocarcinomas.  Dan currently is the VP of Product Development for Amsel Medical Corporation.  Amsel is developing a novel method for the treatment of non-compressible vessel trauma.

Dan is named on numerous patents and patent applications.  Dan holds a bachelor’s degree in Mechanical Engineering from the University of Michigan-Ann Arbor and an MBA from State University of New York-Albany.